Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
13%
Ph phase_1
1
13%
Ph not_applicable
6
75%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting2
unknown1
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 41 (12.5%)
N/A6 (75.0%)

Trials by Status

unknown113%
enrolling_by_invitation113%
not_yet_recruiting113%
completed338%
recruiting225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8